It was recently demonstrated that in MYCN-amplified neuroblastoma cell lines, retinoic acid induces reprogramming of the ADRN CRC, leading to massive downregulation of MYCN expression, tumour suppression, and cell differentiation (Zimmerman et al., 2021). This evidence concerns the gene MYCN and neuroblastoma.